These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34688299)

  • 21. Spondylometaphyseal dysplasia-Sedaghatian type associated with intra-partum cardiac arrhythmia and neonatal death.
    Mahendran SM; Wilcox FL; Chirumamila L
    J Obstet Gynaecol; 2007 Nov; 27(8):851-3. PubMed ID: 18097914
    [No Abstract]   [Full Text] [Related]  

  • 22. Recommendations for patient screening in ultra-rare inherited metabolic diseases: what have we learned from Niemann-Pick disease type C?
    Sobrido MJ; Bauer P; de Koning T; Klopstock T; Nadjar Y; Patterson MC; Synofzik M; Hendriksz CJ
    Orphanet J Rare Dis; 2019 Jan; 14(1):20. PubMed ID: 30665446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of strictly standardized mean difference for hit selection in primary RNA interference high-throughput screening experiments.
    Zhang XD; Ferrer M; Espeseth AS; Marine SD; Stec EM; Crackower MA; Holder DJ; Heyse JF; Strulovici B
    J Biomol Screen; 2007 Jun; 12(4):497-509. PubMed ID: 17435171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Allosteric Activators for Ferroptosis Regulator Glutathione Peroxidase 4.
    Li C; Deng X; Zhang W; Xie X; Conrad M; Liu Y; Angeli JPF; Lai L
    J Med Chem; 2019 Jan; 62(1):266-275. PubMed ID: 29688708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular biology of glutathione peroxidase 4: from genomic structure to developmental expression and neural function.
    Savaskan NE; Ufer C; Kühn H; Borchert A
    Biol Chem; 2007 Oct; 388(10):1007-17. PubMed ID: 17937614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalities.
    Schrader KA; Heravi-Moussavi A; Waters PJ; Senz J; Whelan J; Ha G; Eydoux P; Nielsen T; Gallagher B; Oloumi A; Boyd N; Fernandez BA; Young TL; Jones SJ; Hirst M; Shah SP; Marra MA; Green J; Huntsman DG
    J Pathol; 2011 Sep; 225(1):12-8. PubMed ID: 21792934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatable inherited rare movement disorders.
    Jinnah HA; Albanese A; Bhatia KP; Cardoso F; Da Prat G; de Koning TJ; Espay AJ; Fung V; Garcia-Ruiz PJ; Gershanik O; Jankovic J; Kaji R; Kotschet K; Marras C; Miyasaki JM; Morgante F; Munchau A; Pal PK; Rodriguez Oroz MC; Rodríguez-Violante M; Schöls L; Stamelou M; Tijssen M; Uribe Roca C; de la Cerda A; Gatto EM;
    Mov Disord; 2018 Jan; 33(1):21-35. PubMed ID: 28861905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of patient registries for rare genetic lipid disorders.
    Ng DM; Hooper AJ; Bellgard MI; Burnett JR
    Curr Opin Lipidol; 2018 Apr; 29(2):156-162. PubMed ID: 29351106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing drugs for rare genetic diseases: trends and insights.
    Zitter M
    Manag Care; 2005 Feb; 14(2):52-4, 57-60, 63-4; quiz 66-7. PubMed ID: 15782848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corner fracture type spondylometaphyseal dysplasia: Overlap with type II collagenopathies.
    Machol K; Jain M; Almannai M; Orand T; Lu JT; Tran A; Chen Y; Schlesinger A; Gibbs R; Bonafe L; Campos-Xavier AB; Unger S; Superti-Furga A; Lee BH; Campeau PM; Burrage LC
    Am J Med Genet A; 2017 Mar; 173(3):733-739. PubMed ID: 27888646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opportunities for developing therapies for rare genetic diseases: focus on gain-of-function and allostery.
    Chen B; Altman RB
    Orphanet J Rare Dis; 2017 Apr; 12(1):61. PubMed ID: 28412959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AIFM1-associated X-linked spondylometaphyseal dysplasia with cerebral hypomyelination.
    Edgerley K; Barnicoat A; Offiah AC; Calder AD; Mankad K; Thomas NS; Bunyan DJ; Williams M; Buxton C; Majumdar A; Vijayakumar K; Hilliard T; Turner J; Burren CP; Monsell F; Smithson SF
    Am J Med Genet A; 2021 Apr; 185(4):1228-1235. PubMed ID: 33439541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spondylometaphyseal dysplasia with cone-rod dystrophy.
    Turell M; Morrison S; Traboulsi EI
    Ophthalmic Genet; 2010 Mar; 31(1):12-7. PubMed ID: 20141353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity.
    Brault C; Lévy P; Duponchel S; Michelet M; Sallé A; Pécheur EI; Plissonnier ML; Parent R; Véricel E; Ivanov AV; Demir M; Steffen HM; Odenthal M; Zoulim F; Bartosch B
    Gut; 2016 Jan; 65(1):144-54. PubMed ID: 25516417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The oxido-reductase enzyme glutathione peroxidase 4 (GPX4) governs Salmonella Typhimurium-induced neutrophil transepithelial migration.
    Agbor TA; Demma Z; Mrsny RJ; Castillo A; Boll EJ; McCormick BA
    Cell Microbiol; 2014 Sep; 16(9):1339-53. PubMed ID: 24617613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in PCYT1A cause spondylometaphyseal dysplasia with cone-rod dystrophy.
    Yamamoto GL; Baratela WA; Almeida TF; Lazar M; Afonso CL; Oyamada MK; Suzuki L; Oliveira LA; Ramos ES; Kim CA; Passos-Bueno MR; Bertola DR
    Am J Hum Genet; 2014 Jan; 94(1):113-9. PubMed ID: 24387991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy.
    Wei Y; Lv H; Shaikh AB; Han W; Hou H; Zhang Z; Wang S; Shang P
    Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129539. PubMed ID: 31958545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Diagnostic Approaches for Undiagnosed Rare Genetic Diseases.
    Hartley T; Lemire G; Kernohan KD; Howley HE; Adams DR; Boycott KM
    Annu Rev Genomics Hum Genet; 2020 Aug; 21():351-372. PubMed ID: 32283948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of Glutathione Peroxidase 4 as a Novel Anti-inflammatory Strategy.
    Li C; Deng X; Xie X; Liu Y; Friedmann Angeli JP; Lai L
    Front Pharmacol; 2018; 9():1120. PubMed ID: 30337875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rare diseases and undiagnosed diseases: advances in neurodevelopment].
    Acosta MT
    Medicina (B Aires); 2023 Sep; 83 Suppl 4():52-56. PubMed ID: 37714123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.